Transcription of Q8(R2) - ich.org
{{id}} {{{paragraph}}}
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL DEVELOPMENT Q8(R2) Current Step 4 version dated August 2009 This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. Q8(R2) Document History First Codification History Date Parent Guideline: Pharmaceutical Development Q8 Approval of the Guideline by the Steering Committee under Step 2 and release for public consultation. 18 November 2004 Q8 Approval of the Guideline by the Steering Committee under Step 4 and recommendation for adoption to the three ICH regulatory bodies.
The compatibility of the drug substance with excipients listed in 3.2.P.1 should be evaluated. For products that contain more than one drug substance, the compatibility
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Digidesign Product Compatibility Documents, Download, Product Compatibility, Device Compatibility Pack Updates Customer Tip, Xerox, Compatibility, Product, Building Papers: Products, Standards and Installation, Xerox Product Compatibility, Xerox® Product Compatibility, Mac OS X 10, Dell Enterprise Systems Rail Sizing and, Enterprise Systems Rail Sizing and, Chemical compatibility chart, OS X Mavericks, McAfee ePolicy Orchestrator, CHEMICAL COMPATIBILITY CHART Metallic